{'fraction_non_alphanumeric': 0.038461538461538464, 'fraction_numerical': 0.03698224852071006, 'mean_word_length': 4.93859649122807, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Comment on Steck et al. Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes. Diabetes Care 2014;37:2031–2033

We read with great interest the article by Steck et al. (1) demonstrating that continuous glucose monitoring (CGM) can detect early hyperglycemia in children with positive islet autoantibodies (Ab+) who are at high risk for type 1 diabetes. In fact, the CGM data derived from the group of five subjects who developed type 1 diabetes (Ab+ progressors) showed more impaired glycemia, with percentage of time spent above 140 mg/dL of 31% compared with 12% in Ab+ nonprogressors; Ab+ progressors also had larger SD and …